B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function

Regulatory Peptides

Volumn 167, Issue 1, 2011, Pages 129-133

  Palazzuoli, Alberto ^a   Maisel, Alan ^c   Caputo, Maria ^a   Fineschi, Massimo ^b   Quatrini, Ilaria ^a   Calabrò, Anna ^a   Campagna, Maria Stella ^a   Franci, Beatrice ^a   Grothgar, Stefanie ^a   Pierli, Carlo ^b   Nuti, Ranuccio ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

B type natriuretic peptide; Coronary angiography; Coronary artery disease; Risk stratification

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE CONTRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PEPTIDE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HEART; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

ANGINA;

EID: 79951682748     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.12.011     Document Type: Article

References (26)

1. Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides. [Review]. N Engl J Med 1998, 339:321-328.
2. Arakawa N., Nakamura M., Aoki H., Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 1996, 27:1656-1661.
3. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001, 345:1014-1021.
4. Morrow D.A., De Lemos J.A., Sabatine M.S., et al. Evalutation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST elevation myocardial infarction. J Am Coll Cardiol 2003, 41:1264-1272.
5. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/ non ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000, 284:835-842.
6. Galvani M., Ottani F., Oltrona L., et al. N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes. Circulation 2004, 13(110):128-134.
7. Bazzino O., Fuselli J.J., Botto F., et al. Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST elevation coronary syndromes. Eur Heart J 2004, 25:859-866.
8. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007, 50:e1-e157.
9. Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined- a consensus document of the Joint European Society of cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000, 36:959-969.
10. Schiller N.B., Shah P.N., Crawford M., et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989, 2:358-367.
11. Gibson C.M., Ryan K.A., Kelley M., et al. Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study Group. Am Heart J 1999, 137:1179-1184.
12. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983, 51:606.
13. Omland T., Persson A., Ng L., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002, 106:2913-2918.
14. Sadanandan S., Cannon C.P., Chekuri K., et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2004, 44:564-568.
15. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Circulation 2002, 105:1760-1763.
16. Omland T., Aakvaag A., Bonarjee V.V., et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996, 93:1963-1969.
17. Palazzuoli A., Deckers J., Calabrò A., et al. Brain Natriuretic Peptide and Other Risk Markers for Outcome Assessment in Patients With Non-ST-Elevation Coronary Syndromes and Preserved Systolic Function. Am J Cardiol 2006, 98:1322-1328.
18. Weber M., Dill T., Arnold R., Rau M., Ekinci O., et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 2004, 148:612-620.
19. Omland T., Sabatine M.S., Jablonski K.A., Rice M.M., Hsia J., et al. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease. J Am Coll Cardiol 2007, 50:205-214.
20. Marumoto K., Hamada M., Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris. Clin Sci (Colch) 1995, 88:551-556.
21. Staub D., Nusbaumer C., Zellweger M.J., et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 2006, 151:1223-1230.
22. Burley D.S., Hamid S.A., Baxter G.F. Cardioprotective action of peptide hormones in myocardial ischemia. Heart Fail Rev 2007, 12:279-291.
23. Ndrepepa G., Braun S., Shomig A., Kastrati A. Accuracy of N-terminal Pro-brain Natriuretic Peptide predict mortality in various subset of patients with coronary artery disease. Am J Cardiol 2007, 100:575-578.
24. Barbato E., Rubattu S., Bartunek J., Berni A., Sarno G., et al. Human coronary atherosclerosis modulates cardiac natriuretic peptide release. Atherosclerosis 2009, 206(1):258-264.
25. Bassan R., Potsch A., Maisel A., Tura B., Villacorta H., Nogueira M.V., Campos A., Gamarski R., Masetto A.C., Moutinho M.A. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005, 26:234-240.
26. Kwan G., Isakson S.A., Beede J., Clopton P., Maisel A., et al. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain. J Am Coll Cardiol 2007, 49:1186-1192.